# A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer

> **NCT00001193** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 200 (—)

## Conditions studied

- Breast Neoplasms
- Neoplasm Metastasis

## Interventions

- **PROCEDURE:** high dose melphalan and autologous bone marrow transplantation

## Key facts

- **NCT ID:** NCT00001193
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1984-11
- **Primary completion:** —
- **Final completion:** 2000-09
- **Target enrollment:** 200 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001193, "A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00001193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*